iTonic Holdings Ltd. (ITOC)

Ordinary Shares

Sell: $0.47|Buy: $0.507|Change: 0.01 (1.53%)

Open

$0.512

Previous close

$0.4694

Trade high

$0.5655

Volume

240,239

Year high

$0.9236

Year low

$0.47

Dividend yield

–

Market capitalisation

$8.13 mn

P/E ratio

–

ISIN

KYG713991027

This share can be held in a Dealing account Stocks and shares ISA Lifetime ISA JISA SIPP

Share price

Performance 30/01/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
iTonic Holdings Ltd.	+ 1.53
More...

Company profile

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effectivebrachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.